All In Biotech

Drug Trial Radar · NCT04474314

A Study of IMR-687 in Subjects With Sickle Cell Disease

A Phase 2b Study to Evaluate the Safety and Efficacy of IMR-687 in Subjects With Sickle Cell Disease

Last checked: Nov 20, 2026Latest source record: May 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingRandomized with 115 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

115

Actual

Start

Aug 13, 2020

Primary completion

Mar 2, 2022

Study completion May 4, 2022

Sponsor

Sponsor type
Industry
Collaborators
Imara, Inc.
First posted
Jul 16, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Study to Evaluate the Safety and Efficacy of IMR-687 in Subjects with Sickle Cell Disease

Conditions

  • Sickle Cell Disease

Interventions

  • IMR-687Drug

    Oral administration of once daily IMR-687

  • PlaceboDrug

    Oral administration of once daily Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Effect on the Incidence of Vaso-occlusive Crises (VOCs)Time frame: Baseline to Week 52
  2. Proportion of Patients With Adverse Events and Serious Adverse EventsTime frame: Baseline to Week 56

Locations

49 sites in 13 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham School of Medicine - 1917 Clinic

    Birmingham, Alabama

  • Arkansas Primary Care Clinic

    Little Rock, Arkansas

  • University of California San Diego Moores Cancer Center

    La Jolla, California

  • Center For Inherited Blood Disorders

    Santa Ana, California

  • The Oncology Institute Long Beach

    Whittier, California

  • University of Connecticut Health Main Building

    Farmington, Connecticut

  • Children's Healthcare of Atlanta

    Atlanta, Georgia

  • The University of Illinois at Chicago College of Medicine

    Chicago, Illinois

  • Johns Hopkins Hospital

    Baltimore, Maryland

  • Children's Hospital of Michigan

    Detroit, Michigan

  • Newark Beth Israel Medical Center

    Newark, New Jersey

  • Weill Cornell Medicine - Center for Blood Disorders

    New York, New York

  • Baylor Scott & White Medical Center-Temple

    Temple, Texas

  • Virginia Commonwealth University Health - Ambulatory Care Center

    Richmond, Virginia

  • Korle Bu Teaching Hospital

    Accra, Ghana

  • Kintampo Health Research Centre

    Kintampo, Ghana

  • University General Hospital of Patras

    Pátrai, Greece

  • Ippokrateio General Hospital of Thessaloniki

    Thessaloniki, Greece

  • Laiko General Hospital of Athens

    Athens, Attica, Greece

  • Ente Ospedaliero Ospedali Galliera

    Genoa, Italy

  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

    Milan, Italy

  • Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello

    Palermo, Italy

  • Azienda Ospedaliero - Universitaria San Luigi Gonzaga

    Turin, Orbassano, Italy

  • Fondazione Policlinico Universitario Agostino Gemelli

    Roma, Rome, Italy

  • Gertrude's Children's Hospital

    Nairobi, Kenya

  • The Centre for Respiratory Diseases Research - Kenya Medical Research Institute

    Nairobi, Kenya

  • Kenya Medical Research Institute - Kisumu

    Kisumu, Nyanza, Kenya

  • American University of Beirut Medical Center

    Beirut, Lebanon

  • Chronic Care Center

    Hazmiyeh, Lebanon

  • Hopital Nini

    Tripoli, North Governorate, Lebanon

  • Hôpital d'Enfants Rabat

    Rabat, Morocco

  • Hagaziekenhuis Van Den Haag - Leyweg

    The Hague, South Holland, Netherlands

  • Sultan Qaboos University Hospital

    Muscat, Oman

  • Centre National De Transfusion Sanguine - Du Senegal

    Dakar, Senegal

  • Hedi Chaker Hospital

    Sfax, Tunisia

  • Centre Hôpital Universitaire Farhat Hached

    Sousse, Tunisia

  • Centre National de Greffe de la Moelle Osseuse

    Tunis, Tunisia

  • Hospital Aziza Othmana

    Tunis, Tunisia

  • Jinja Regional Referral Hospital

    Jinja, Uganda

  • Uganda Cancer Institute

    Kampala, Uganda

Showing 40 of 49 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.